News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Is 5-year interval sufficient for prostate cancer screening in older men?
18 Aug 2022
byRoshini Claire Anthony
Diagnosis, progression, or death due to prostate cancer occur at approximately a decade to 15 years following an initial assessment of prostate-specific antigen (PSA) levels in older men, according to a study presented at EAU 2022.
18 Aug 2022

MTX treatment break improves COVID-19 booster response in patients with IMIDs
18 Aug 2022
byAudrey Abella
In individuals with immune-mediated inflammatory diseases (IMIDs*), a 2-week interruption in methotrexate (MTX) treatment led to enhanced COVID-19 booster vaccine response compared with those who continued with MTX treatment, according to findings from the VROOM** study.
18 Aug 2022

Local failure tied to survival in intermediate-risk PCa after definitive radiotherapy
18 Aug 2022
byTristan Manalac
In men with intermediate- or high-risk prostate cancer (PCa), local failure after definitive radiation therapy (RT) is indicative of survival outcomes, according to a recent study.
18 Aug 2022






